CIDRAP newsletters options
More than 2 million American workers called in sick in a single week in mid-April, causing the highest absence rate on record and leading to suspicions that COVID-19 cases were substantially undercounted, according to a research letter published yesterday in JAMA Internal Medicine.
The vaccine trial is starting against a backdrop of a vigorous US outbreak, in which three states outside the main hot spots reported record highs: Oklahoma, Missouri, and North Dakota.
Two German studies published today in JAMA Cardiology show abnormal heart imaging findings in recently recovered COVID-19 patients.
WHO officials stressed that even intense transmission countries can turn their outbreaks around with leadership, consistent messaging, and key measures.
In a comparative analysis published late last week in Clinical Infectious Diseases, the antiviral drug remdesivir was linked to significantly greater recovery and a 62% lower death rate by day 14 versus standard treatment in hospitalized adults with severe COVID-19.
Two more Ebola infections and two more deaths from the virus have been reported from the Democratic Republic of the Congo (DRC) Equateur province outbreak, the World Health Organization (WHO) African regional office said on Twitter today.
In India, surging COVID-19 has led to remdesivir shortages, and the outbreak is expanding in Brazil.
"We need to reopen the schools with the understanding the virus is still here," CDC Director Robert Redfield says.
A plague outbreak in the Democratic Republic of the Congo (DRC) that began on June likely involves all three types, including pneumonic, and has so far resulted in 45 cases, 9 of them fatal, the World Health Organization (WHO) said yesterday in a statement.
A study yesterday in The Lancet Child & Adolescent Health found no evidence of COVID-19 transmission between 120 babies born to mothers with COVID-19, even after 2 weeks of breastfeeding with appropriate hygiene precautions.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Scientists in Luxembourg this week announced the creation of a new biobank that will collect and analyze strains of bacteria from Europe that are resistant to last-resort antibiotics.
About 47% of US adults have an underlying condition strongly tied to severe COVID-19 illness.
WHO head reiterates that political leadership and community engagement are the 2 key response pillars.
July continues to look like April for the US, just as pro baseball opens.
A randomized controlled trial of hospitalized COVID-19 patients in Brazil found that the use of hydroxychloroquine, with or without azithromycin, did not improve clinical status at 15 days compared with standard care, researchers reported today in the New England Journal of Medicine.
A 2019 survey of clinical commissioning groups in England showed an increase in antimicrobial stewardship (AMS) programs compared with the previous survey, according to a report yesterday from UK nonprofit The Patients Association.
In the past day, the US, Brazil, and India reported more than 143,000 new cases combined.
Antibody levels dropped by about half every 73 days—not good news for vaccine prospects.
For the first time in more than a month, daily US deaths top 1,000.
Dr. Osterholm clarifies that he supports the wearing of cloth face coverings in public and urges people to stop citing CIDRAP and him as grounds for not wearing masks, but he also asks that advocates not use poorly conducted studies to support their use.
